Thioacetazone
Clinical data | |
---|---|
Routes of administration | Oral |
ATC code | |
Identifiers | |
| |
CAS Number | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C10H12N4OS |
Molar mass | 236.3 |
WikiDoc Resources for Thioacetazone |
Articles |
---|
Most recent articles on Thioacetazone Most cited articles on Thioacetazone |
Media |
Powerpoint slides on Thioacetazone |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Thioacetazone at Clinical Trials.gov Trial results on Thioacetazone Clinical Trials on Thioacetazone at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Thioacetazone NICE Guidance on Thioacetazone
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Thioacetazone Discussion groups on Thioacetazone Patient Handouts on Thioacetazone Directions to Hospitals Treating Thioacetazone Risk calculators and risk factors for Thioacetazone
|
Healthcare Provider Resources |
Causes & Risk Factors for Thioacetazone |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Thioacetazone(INN and BAN) is also called thiocetazone, thiacetazone, thiosemicarbazone, benzothiozane or amithiozone(USAN); abbreviated T.
Thioacetazone is used in the treatment of tuberculosis; it has only weak activity against Mycobacterium tuberculosis and is only useful in preventing resistance to more powerful drugs like isoniazid and rifampicin. It is never used on its own to treat tuberculosis; it is used in a similar way to ethambutol. Thioacetazone is the only anti-TB drug that is ineffective when given intermittently.
There is no advantage to using thioacetazone if the regimen used already contains ethambutol, but many countries in sub-Saharan Africa still use thioacetazone because it is extremely cheap. Use of thioacetazone is declining because it can cause severe (sometimes fatal) skin reactions in HIV positive patients.[1][2]
References
- ↑ Rieder HL, Arnadottir T, Trebucq A, Enarson DA (2001). "Tuberculosis treatment: dangerous regimens?". Int J Tuberc Lung Dis. 5 (1): 1&ndash, 3. PMID 11263509.
- ↑ Nunn P, Porter J, Winstanley P (1993). "Thiacetazone—avoid like poison or use with care?". Trans R Soc Trop Med Hyg. 87 (5): 578&ndash, 82. PMID 7505496.
- Pages with script errors
- CS1 maint: Multiple names: authors list
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Antibiotics
- Tuberculosis